Genentech, Inc. - Company & Market Research Reports

Home /
Companies /
Genentech, Inc.

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 114
Immune Disorders Drugs 49
Biopharmaceuticals 37
Central Nervous System Drugs 33
Genomics 33
Drug Discovery 30
Optical Disorders Drugs 27
Optical 27
Pharmaceuticals 26
Respiratory Drugs 25
Biotechnology 23
Hematological Drugs 23
Endocrine and Metabolic Disorders Drugs 22
Cardiovascular Drugs 19
Clinical Trials 19
Breast Cancer Drugs 18
Women's Health 17
Lung Cancer Drugs 17
Infusions and Injectables 17
Musculoskeletal Disorders Drugs 17
Infectious Diseases Drugs 15
Oncology 15
Allergy and Immunology 14
Biosimilars and Biosuperiors 14
Liver and Kidney Disorders Drugs 13
Pulmonary Medicine 12
Leukemia Drugs 12
Lymphoma Drugs 12
Colon Cancer Drugs 12
Enzymes 12
Skin Cancer Drugs 11
Pharmaceutical Manufacturing 11
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Diagnostics 10
Kidney Cancer Drugs 10
Brain Cancer Drugs 9
Drug Delivery 9
Needles and Syringes 8
Allergy Drugs 8
Bladder Cancer Drugs 7
Hematology 7
Pancreatic Cancer Drugs 7
Dermatological Drugs 7
Liver Cancer Drugs 6
Sexual and Reproductive Health Drugs 6
Therapeutic Area 5
Drugs by Therapeutic Area 5
Gastrointestinal Drugs 5
Urological Disorders Drugs 5
Immunosuppressive Drugs 5
Pharmaceutical Intermediates 4
Neurology 4
Healthcare Services 4
Hospital Information Systems 4
Dermatology 4
Vaccines 4
Diabetes Drugs 3
Prostate Cancer Drugs 3
In Vitro Diagnostics 3
Transdermal and Transmucosal Drug Delivery 3
Medical Devices 3
Thyroid Cancer Drugs 3
Cardiology 3
Alzheimer's Disease Drugs 3
Company Reports 2
Animal Pharmaceuticals 2
Urology and Nephrology 2
Proteomics 2
Infectious Disease Testing 2
Laboratory Testing 2
Biomaterials 2
Cancer Vaccines 2
Uterine Cancer Drugs 2
Nanomedicine 2
Laboratory Equipment 2
Pediatrics 2
HIV/AIDS Drugs 2
Psoriasis Drugs 2
Patient Monitoring Equipment 1
Generic Drugs 1
Pharmacoeconomics 1
Medical Imaging 1
Drug Abuse Screening 1
Analgesics 1
Cough and Cold Drugs 1
Managed Care 1
Radiography 1
Stem Cells 1
Biomarkers 1
Over the Counter (OTC) Drugs 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Vitamins and Dietary Supplements 1
Antibiotics 1
Gastroenterology 1
Endocrinology 1
Maternal and Neonatal Care 1
Asthma Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



283 reviews

682 Results (Page 24 of 35)
- Relevance
  Sort by

Stomach Cancer Treatment Market - Global Strategic Business Report

 Report
May 2026
371 Pages
Global

From

€5170EUR$5,850USD£4,477GBP

MEK Inhibitors - Global Strategic Business Report

 Report
May 2026
132 Pages
Global

From

€5170EUR$5,850USD£4,477GBP

Head and Neck Cancer Therapeutics - Global Strategic Business Report

 Report
May 2026
183 Pages
Global

From

€5170EUR$5,850USD£4,477GBP

Urothelial Cancer Drugs - Global Strategic Business Report

 Report
May 2026
126 Pages
Global

From

€5170EUR$5,850USD£4,477GBP

Oral Cancer Treatment - Global Strategic Business Report

 Report
May 2026
279 Pages
Global

From

€5170EUR$5,850USD£4,477GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Blastic Plasmacytoid Dendritic Cell Neoplasm - Global Strategic Business Report

 Report
May 2026
285 Pages
Global

From

€5170EUR$5,850USD£4,477GBP

Collaboration Deals in Biotechnology 2020-2026

 Report
March 2026
950 Pages
Global

From

€4414EUR$4,995USD£3,823GBP

Chronic Spontaneous Urticaria - Market Insight, Epidemiology, and Market Forecast - 2034

 Report
April 2025
200 Pages
Global

From

€7025EUR$7,950USD£6,084GBP

Rare Disease & Orphan Therapeutic Market Analysis & Forecast to 2025

 Report
December 2020
197 Pages
Global

From

€4330EUR$4,900USD£3,750GBP

Spinal Muscular Atrophy Treatment Market Size, Share & Trends Analysis Report By Type, By Treatment, By Route of Administration, By Region, And Segment Forecasts, 2025 - 2030

 Report
December 2024
100 Pages
Global

From

€5258EUR$5,950USD£4,554GBP

Cancer Immunotherapy Market Size, Share & Trends Analysis Report by Product (Monoclonal Antibodies, Immunomodulators), Application, Distribution Channel, End Use, and Region with Growth Forecasts, 2026-2033

 Report
December 2025
150 Pages
Global

From

€5258EUR$5,950USD£4,554GBP

Kidney Cancer Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
February 2024
93 Pages
Global

From

€3500EUR$4,243USD£3,137GBP

Next Generation Complement Therapeutics Market: Distribution by Target Disease Indication, Therapeutic Area, Type of Molecule, Target Pathway, Type of Therapy, Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
February 2022
131 Pages
Global

From

€4241EUR$4,799USD£3,673GBP

Next-Generation Antibody Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3968EUR$4,490USD£3,436GBP

Therapeutic Proteins Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3968EUR$4,490USD£3,436GBP

Cancer biologics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3968EUR$4,490USD£3,436GBP

Investigation Report on China's Pertuzumab Market 2021-2025

 Report
June 2021
50 Pages
China

From

€2298EUR$2,600USD£1,990GBP

Primary Sclerosing Cholangitis - Pipeline Insight, 2025

 Clinical Trials
April 2025
50 Pages
Global

From

€1326EUR$1,500USD£1,148GBP

Inotropic Agents Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3968EUR$4,490USD£3,436GBP

Acute Ischemic Stroke Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3968EUR$4,490USD£3,436GBP

682 Results (Page 24 of 35)
- 1
- 22
- 23
- 24
- 25
- 26

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.